 | • レポートコード：GIR-2104Z00899 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、動物用抗菌ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。動物用抗菌ペプチドの種類別市場規模（アニオン性ペプチド、カチオン性ペプチド）、用途別市場規模（家禽、家畜）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・動物用抗菌ペプチドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merial、Zoetis、Bayer HealthCare、Merck Animal Health、Elanco (Eli Lilly and Company)、Biogenesis Bago、Animal Medics、Boehringer Ingelheim Vetmedica ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アニオン性ペプチド、カチオン性ペプチド ・用途別分析2016年-2026年：家禽、家畜 ・動物用抗菌ペプチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・動物用抗菌ペプチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・動物用抗菌ペプチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・動物用抗菌ペプチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・動物用抗菌ペプチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Animal Antibacterial Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Animal Antibacterial Peptide size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Animal Antibacterial Peptide market size is expected to grow at a CAGR of 3.8% for the next five years.
Market segmentation
Animal Antibacterial Peptide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anionic Peptides
Cationic Peptide
Market segment by Application can be divided into
Poultry
Livestock
The key market players for global Animal Antibacterial Peptide market are listed below:
Merial
Zoetis
Bayer HealthCare
Merck Animal Health
Elanco (Eli Lilly and Company)
Biogenesis Bago
Animal Medics
Boehringer Ingelheim Vetmedica
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Animal Antibacterial Peptide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Animal Antibacterial Peptide Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Anionic Peptides
1.2.3 Cationic Peptide
1.3 Market Analysis by Application
1.3.1 Overview: Global Animal Antibacterial Peptide Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Poultry
1.3.3 Livestock
1.4 Global Animal Antibacterial Peptide Market Size & Forecast
1.4.1 Global Animal Antibacterial Peptide Sales in Value (2016-2026))
1.4.2 Global Animal Antibacterial Peptide Sales in Volume (2016-2026)
1.4.3 Global Animal Antibacterial Peptide Price by Type (2016-2026) & (USD/MT)
1.5 Global Animal Antibacterial Peptide Production Capacity Analysis
1.5.1 Global Animal Antibacterial Peptide Total Production Capacity (2016-2026)
1.5.2 Global Animal Antibacterial Peptide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal Antibacterial Peptide Market Drivers
1.6.2 Animal Antibacterial Peptide Market Restraints
1.6.3 Animal Antibacterial Peptide Trends Analysis
2 Manufacturers Profiles
2.1 Merial
2.1.1 Merial Details
2.1.2 Merial Major Business
2.1.3 Merial Animal Antibacterial Peptide Product and Services
2.1.4 Merial Animal Antibacterial Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Animal Antibacterial Peptide Product and Services
2.2.4 Zoetis Animal Antibacterial Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bayer HealthCare
2.3.1 Bayer HealthCare Details
2.3.2 Bayer HealthCare Major Business
2.3.3 Bayer HealthCare Animal Antibacterial Peptide Product and Services
2.3.4 Bayer HealthCare Animal Antibacterial Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business
2.4.3 Merck Animal Health Animal Antibacterial Peptide Product and Services
2.4.4 Merck Animal Health Animal Antibacterial Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Elanco (Eli Lilly and Company)
2.5.1 Elanco (Eli Lilly and Company) Details
2.5.2 Elanco (Eli Lilly and Company) Major Business
2.5.3 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product and Services
2.5.4 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Biogenesis Bago
2.6.1 Biogenesis Bago Details
2.6.2 Biogenesis Bago Major Business
2.6.3 Biogenesis Bago Animal Antibacterial Peptide Product and Services
2.6.4 Biogenesis Bago Animal Antibacterial Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Animal Medics
2.7.1 Animal Medics Details
2.7.2 Animal Medics Major Business
2.7.3 Animal Medics Animal Antibacterial Peptide Product and Services
2.7.4 Animal Medics Animal Antibacterial Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Boehringer Ingelheim Vetmedica
2.8.1 Boehringer Ingelheim Vetmedica Details
2.8.2 Boehringer Ingelheim Vetmedica Major Business
2.8.3 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product and Services
2.8.4 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Animal Antibacterial Peptide Sales by Manufacturer
3.1 Global Animal Antibacterial Peptide Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Animal Antibacterial Peptide Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Animal Antibacterial Peptide
3.4 Market Concentration Rate
3.4.1 Top 3 Animal Antibacterial Peptide Manufacturer Market Share
3.4.2 Top 6 Animal Antibacterial Peptide Manufacturer Market Share
3.5 Global Animal Antibacterial Peptide Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Animal Antibacterial Peptide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Animal Antibacterial Peptide Market Size by Region
4.1.1 Global Animal Antibacterial Peptide Sales in Volume by Region (2016-2026)
4.1.2 Global Animal Antibacterial Peptide Revenue by Region (2016-2026)
4.2 North America Animal Antibacterial Peptide Revenue (2016-2026)
4.3 Europe Animal Antibacterial Peptide Revenue (2016-2026)
4.4 Asia-Pacific Animal Antibacterial Peptide Revenue (2016-2026)
4.5 South America Animal Antibacterial Peptide Revenue (2016-2026)
4.6 Middle East and Africa Animal Antibacterial Peptide Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Animal Antibacterial Peptide Sales in Volume by Type (2016-2026)
5.2 Global Animal Antibacterial Peptide Revenue by Type (2016-2026)
5.3 Global Animal Antibacterial Peptide Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Animal Antibacterial Peptide Sales in Volume by Application (2016-2026)
6.2 Global Animal Antibacterial Peptide Revenue by Application (2016-2026)
6.3 Global Animal Antibacterial Peptide Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Animal Antibacterial Peptide Sales by Type (2016-2026)
7.2 North America Animal Antibacterial Peptide Sales by Application (2016-2026)
7.3 North America Animal Antibacterial Peptide Market Size by Country
7.3.1 North America Animal Antibacterial Peptide Sales in Volume by Country (2016-2026)
7.3.2 North America Animal Antibacterial Peptide Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Animal Antibacterial Peptide Sales by Type (2016-2026)
8.2 Europe Animal Antibacterial Peptide Sales by Application (2016-2026)
8.3 Europe Animal Antibacterial Peptide Market Size by Country
8.3.1 Europe Animal Antibacterial Peptide Sales in Volume by Country (2016-2026)
8.3.2 Europe Animal Antibacterial Peptide Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Animal Antibacterial Peptide Sales by Type (2016-2026)
9.2 Asia-Pacific Animal Antibacterial Peptide Sales by Application (2016-2026)
9.3 Asia-Pacific Animal Antibacterial Peptide Market Size by Region
9.3.1 Asia-Pacific Animal Antibacterial Peptide Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Animal Antibacterial Peptide Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Animal Antibacterial Peptide Sales by Type (2016-2026)
10.2 South America Animal Antibacterial Peptide Sales by Application (2016-2026)
10.3 South America Animal Antibacterial Peptide Market Size by Country
10.3.1 South America Animal Antibacterial Peptide Sales in Volume by Country (2016-2026)
10.3.2 South America Animal Antibacterial Peptide Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Animal Antibacterial Peptide Sales by Type (2016-2026)
11.2 Middle East & Africa Animal Antibacterial Peptide Sales by Application (2016-2026)
11.3 Middle East & Africa Animal Antibacterial Peptide Market Size by Country
11.3.1 Middle East & Africa Animal Antibacterial Peptide Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Animal Antibacterial Peptide Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Animal Antibacterial Peptide Typical Distributors
12.3 Animal Antibacterial Peptide Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Animal Antibacterial Peptide Revenue by Type, (USD Million), 2021-2026
Table 2. Global Animal Antibacterial Peptide Revenue by Application, (USD Million), 2021-2026
Table 3. Merial Basic Information, Manufacturing Base and Competitors
Table 4. Merial Major Business
Table 5. Merial Animal Antibacterial Peptide Product and Services
Table 6. Merial Animal Antibacterial Peptide Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Zoetis Basic Information, Manufacturing Base and Competitors
Table 8. Zoetis Major Business
Table 9. Zoetis Animal Antibacterial Peptide Product and Services
Table 10. Zoetis Animal Antibacterial Peptide Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 12. Bayer HealthCare Major Business
Table 13. Bayer HealthCare Animal Antibacterial Peptide Product and Services
Table 14. Bayer HealthCare Animal Antibacterial Peptide Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 16. Merck Animal Health Major Business
Table 17. Merck Animal Health Animal Antibacterial Peptide Product and Services
Table 18. Merck Animal Health Animal Antibacterial Peptide Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Elanco (Eli Lilly and Company) Basic Information, Manufacturing Base and Competitors
Table 20. Elanco (Eli Lilly and Company) Major Business
Table 21. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product and Services
Table 22. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Biogenesis Bago Basic Information, Manufacturing Base and Competitors
Table 24. Biogenesis Bago Major Business
Table 25. Biogenesis Bago Animal Antibacterial Peptide Product and Services
Table 26. Biogenesis Bago Animal Antibacterial Peptide Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Animal Medics Basic Information, Manufacturing Base and Competitors
Table 28. Animal Medics Major Business
Table 29. Animal Medics Animal Antibacterial Peptide Product and Services
Table 30. Animal Medics Animal Antibacterial Peptide Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Boehringer Ingelheim Vetmedica Basic Information, Manufacturing Base and Competitors
Table 32. Boehringer Ingelheim Vetmedica Major Business
Table 33. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product and Services
Table 34. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Animal Antibacterial Peptide Sales by Manufacturer (2019-2021e) & (K MT)
Table 36. Global Animal Antibacterial Peptide Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Animal Antibacterial Peptide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Animal Antibacterial Peptide Production Capacity by Company, (K MT): 2020 VS 2021
Table 39. Head Office and Animal Antibacterial Peptide Production Site of Key Manufacturer
Table 40. Global Animal Antibacterial Peptide Sales by Region (2016-2021e) & (K MT)
Table 41. Global Animal Antibacterial Peptide Sales by Region (2021-2026) & (K MT)
Table 42. Global Animal Antibacterial Peptide Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Animal Antibacterial Peptide Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Animal Antibacterial Peptide Sales by Type (2016-2021e) & (K MT)
Table 45. Global Animal Antibacterial Peptide Sales by Type (2021-2026) & (K MT)
Table 46. Global Animal Antibacterial Peptide Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Animal Antibacterial Peptide Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Animal Antibacterial Peptide Price by Type (2016-2021e) & (USD/MT)
Table 49. Global Animal Antibacterial Peptide Price by Type (2021-2026) & (USD/MT)
Table 50. Global Animal Antibacterial Peptide Sales by Application (2016-2021e) & (K MT)
Table 51. Global Animal Antibacterial Peptide Sales by Application (2021-2026) & (K MT)
Table 52. Global Animal Antibacterial Peptide Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Animal Antibacterial Peptide Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Animal Antibacterial Peptide Price by Application (2016-2021e) & (USD/MT)
Table 55. Global Animal Antibacterial Peptide Price by Application (2021-2026) & (USD/MT)
Table 56. North America Animal Antibacterial Peptide Sales by Country (2016-2021e) & (K MT)
Table 57. North America Animal Antibacterial Peptide Sales by Country (2021-2026) & (K MT)
Table 58. North America Animal Antibacterial Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Animal Antibacterial Peptide Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Animal Antibacterial Peptide Sales by Type (2016-2021e) & (K MT)
Table 61. North America Animal Antibacterial Peptide Sales by Type (2021-2026) & (K MT)
Table 62. North America Animal Antibacterial Peptide Sales by Application (2016-2021e) & (K MT)
Table 63. North America Animal Antibacterial Peptide Sales by Application (2021-2026) & (K MT)
Table 64. Europe Animal Antibacterial Peptide Sales by Country (2016-2021e) & (K MT)
Table 65. Europe Animal Antibacterial Peptide Sales by Country (2021-2026) & (K MT)
Table 66. Europe Animal Antibacterial Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Animal Antibacterial Peptide Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Animal Antibacterial Peptide Sales by Type (2016-2021e) & (K MT)
Table 69. Europe Animal Antibacterial Peptide Sales by Type (2021-2026) & (K MT)
Table 70. Europe Animal Antibacterial Peptide Sales by Application (2016-2021e) & (K MT)
Table 71. Europe Animal Antibacterial Peptide Sales by Application (2021-2026) & (K MT)
Table 72. Asia-Pacific Animal Antibacterial Peptide Sales by Region (2016-2021e) & (K MT)
Table 73. Asia-Pacific Animal Antibacterial Peptide Sales by Region (2021-2026) & (K MT)
Table 74. Asia-Pacific Animal Antibacterial Peptide Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Animal Antibacterial Peptide Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Animal Antibacterial Peptide Sales by Type (2016-2021e) & (K MT)
Table 77. Asia-Pacific Animal Antibacterial Peptide Sales by Type (2021-2026) & (K MT)
Table 78. Asia-Pacific Animal Antibacterial Peptide Sales by Application (2016-2021e) & (K MT)
Table 79. Asia-Pacific Animal Antibacterial Peptide Sales by Application (2021-2026) & (K MT)
Table 80. South America Animal Antibacterial Peptide Sales by Country (2016-2021e) & (K MT)
Table 81. South America Animal Antibacterial Peptide Sales by Country (2021-2026) & (K MT)
Table 82. South America Animal Antibacterial Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Animal Antibacterial Peptide Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Animal Antibacterial Peptide Sales by Type (2016-2021e) & (K MT)
Table 85. South America Animal Antibacterial Peptide Sales by Type (2021-2026) & (K MT)
Table 86. South America Animal Antibacterial Peptide Sales by Application (2016-2021e) & (K MT)
Table 87. South America Animal Antibacterial Peptide Sales by Application (2021-2026) & (K MT)
Table 88. Middle East & Africa Animal Antibacterial Peptide Sales by Country (2016-2021e) & (K MT)
Table 89. Middle East & Africa Animal Antibacterial Peptide Sales by Country (2021-2026) & (K MT)
Table 90. Middle East & Africa Animal Antibacterial Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Animal Antibacterial Peptide Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Animal Antibacterial Peptide Sales by Type (2016-2021e) & (K MT)
Table 93. Middle East & Africa Animal Antibacterial Peptide Sales by Type (2021-2026) & (K MT)
Table 94. Middle East & Africa Animal Antibacterial Peptide Sales by Application (2016-2021e) & (K MT)
Table 95. Middle East & Africa Animal Antibacterial Peptide Sales by Application (2021-2026) & (K MT)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Animal Antibacterial Peptide Typical Distributors
Table 99. Animal Antibacterial Peptide Typical Customers
List of Figures
Figure 1. Animal Antibacterial Peptide Picture
Figure 2. Global Animal Antibacterial Peptide Sales Market Share by Type in 2020
Figure 3. Anionic Peptides
Figure 4. Cationic Peptide
Figure 5. Global Animal Antibacterial Peptide Sales Market Share by Application in 2020
Figure 6. Poultry
Figure 7. Livestock
Figure 8. Global Animal Antibacterial Peptide Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 9. Global Animal Antibacterial Peptide Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Animal Antibacterial Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Animal Antibacterial Peptide Sales (2016-2026) & (K MT)
Figure 30. Global Animal Antibacterial Peptide Production Capacity (2016-2026) & (K MT)
Figure 31. Global Animal Antibacterial Peptide Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Animal Antibacterial Peptide Market Drivers
Figure 33. Animal Antibacterial Peptide Market Restraints
Figure 34. Animal Antibacterial Peptide Market Trends
Figure 35. Global Animal Antibacterial Peptide Sales Market Share by Manufacturer in 2020
Figure 36. Global Animal Antibacterial Peptide Revenue Market Share by Manufacturer in 2020
Figure 37. Animal Antibacterial Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Animal Antibacterial Peptide Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Animal Antibacterial Peptide Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Animal Antibacterial Peptide Sales Market Share by Region (2016-2026)
Figure 41. Global Animal Antibacterial Peptide Revenue Market Share by Region (2016-2026)
Figure 42. North America Animal Antibacterial Peptide Revenue (2016-2026) & (USD Million)
Figure 43. Europe Animal Antibacterial Peptide Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Animal Antibacterial Peptide Revenue (2016-2026) & (USD Million)
Figure 45. South America Animal Antibacterial Peptide Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Animal Antibacterial Peptide Revenue (2016-2026) & (USD Million)
Figure 47. Global Animal Antibacterial Peptide Sales Market Share by Type (2016-2026)
Figure 48. Global Animal Antibacterial Peptide Revenue Market Share by Type (2016-2026)
Figure 49. Global Animal Antibacterial Peptide Price by Type (2016-2026) & (USD/MT)
Figure 50. Global Animal Antibacterial Peptide Sales Market Share by Application (2016-2026)
Figure 51. Global Animal Antibacterial Peptide Revenue Market Share by Application (2016-2026)
Figure 52. Global Animal Antibacterial Peptide Price by Application (2016-2026) & (USD/MT)
Figure 53. North America Animal Antibacterial Peptide Sales Market Share by Country (2016-2026)
Figure 54. North America Animal Antibacterial Peptide Revenue Market Share by Country (2016-2026)
Figure 55. North America Animal Antibacterial Peptide Sales Market Share by Type (2016-2026)
Figure 56. North America Animal Antibacterial Peptide Sales Market Share by Application (2016-2026)
Figure 57. Europe Animal Antibacterial Peptide Sales Market Share by Country (2016-2026)
Figure 58. Europe Animal Antibacterial Peptide Revenue Market Share by Country (2016-2026)
Figure 59. Europe Animal Antibacterial Peptide Sales Market Share by Type (2016-2026)
Figure 60. Europe Animal Antibacterial Peptide Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Animal Antibacterial Peptide Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Animal Antibacterial Peptide Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Animal Antibacterial Peptide Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Animal Antibacterial Peptide Sales Market Share by Application (2016-2026)
Figure 65. South America Animal Antibacterial Peptide Sales Market Share by Country (2016-2026)
Figure 66. South America Animal Antibacterial Peptide Revenue Market Share by Country (2016-2026)
Figure 67. South America Animal Antibacterial Peptide Sales Market Share by Type (2016-2026)
Figure 68. South America Animal Antibacterial Peptide Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Animal Antibacterial Peptide Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Animal Antibacterial Peptide Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Animal Antibacterial Peptide Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Animal Antibacterial Peptide Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の動物用抗菌・抗生物質市場規模・現状・予測（2021年-2027年） Animal Antibacterial and Antibiotics are usually used in animal feed, antibiotic use whether for therapy or prevention of bacterial diseases, or as performance enhancers will result in antibiotic resistant micro-organisms, not only among pathogens but also among bacteria of the endogenous microflora…- 世界のペプチドベース胃腸障害治療薬市場規模・現状・予測（2021年-2027年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…
- 世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- 世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- 世界のペプチドベース癌治療薬市場規模・現状・予測（2021年-2027年） Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. Market Analysis and Insights: Global Peptide Based Cancer Therapeuti…